PTSM: Pharmaceutical Technology Sourcing and Management-02-01-2012

A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.

Venture-capital financing was up last year in the US biotechnology industry, but public-equity financing, exclusive of debt, declined.

Improving R&D productivity, life-cycle management, and operational efficiency are key approaches for enhancing growth prospects.

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Pharmaceutical companies pledge donations of 14 billion treatments for the next decade to combat nine neglected tropical diseases.